부산대학교 도서관

Humphrys, E; Rodgers, J; Asquith, NL; Yaghi, SA; Foulstone, A; Thorneycroft, R; Cook, PS

Bahl A; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Wilson W; Cancer Research UK & UCL Cancer Trials Centre, UK.; Ball J; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Renninson E; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK. Electronic address: Amit.Bahl@uhbw.nhs.uk.; Dubey S; Derriford Hospital, Plymouth, UK.; Bravo A; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Foulstone E; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Spensley S; Musgrove Hospital, Taunton, UK.; Bowen R; Royal United Hospital, Bath, UK.; Mansi J; Guy's Hospital, London, UK.; Waters S; Velindre Cancer Centre, Cardiff, UK.; Riddle P; Charing Cross Hospital, London, UK.; Wheatley D; Royal Cornwall Hospital, Truro, UK.; Stephens P; Royal Devon and Exeter Hospital, Exeter, UK.; Bezecny P; Blackpool Victoria Hospital, Blackpool, UK.; Madhusudan S; City Hospital, Nottingham, UK.; Verrill M; Freeman Hospital, Newcastle, UK.; Braybrooke J; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Comins C; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Mohan V; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Gee A; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Kirk H; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Markham A; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Evans H; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Watson E; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Callaway M; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Pearson S; Bristol Haematology and Oncology Clinical Trial Unit, University Hospitals Bristol and Weston NHS Foundation Trust, UK.; Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, UK.; Churn M; Worcester Royal Hospital, Worcester, UK.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

Shepherd, PR; Nave, BT; Rincon, J; Haigh, RJ; Foulstone, E; Proud, C; Zierath, JR; Siddle, K; WallbergHenriksson, H

Diabetologia. 40(10):1172-1177

Foulstone, E.; Holly, J.M.P.; Zeng, L.; Winters, Z.E.; Perks, C.M.

Growth Hormone & IGF Research. 20:S63-S64

Zeng, L.; Foulstone, E.; Holly, J.; Perks, C.

Growth Hormone & IGF Research. 22:S80-S80

Wang, J.; Perks, C.; Foulstone, E.; Ladomery, M.L.; Holly, J.

Growth Hormone & IGF Research. 22:S73-S73

Zeng, L.; Foulstone, E.; Holly, J.; Perks, C.

Growth Hormone & IGF Research. 22:S38-S38

Challapalli A; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.; Masson S; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.; White P; Department of Statistics, University of the West of England, Bristol, UK.; Dailami N; Department of Statistics, University of the West of England, Bristol, UK.; Pearson S; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.; Rowe E; Department of Urology, Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK.; Koupparis A; Department of Urology, Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK.; Oxley J; Department of Pathology, North Bristol NHS Trust, Bristol, UK.; Abdelaziz A; Department of Oncology, Ain Shams University Hospitals, Egypt.; Ash-Miles J; Department of Radiology, North Bristol NHS Trust, Bristol, UK.; Bravo A; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.; Foulstone E; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.; Perks C; IGFs & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Holly J; IGFs & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Persad R; Department of Urology, Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK.; Bahl A; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK. Electronic address: Amitbahl@doctors.org.uk.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Anderson E; University of the West of England, Bristol, United Kingdom. Electronic address: elizabeth3.anderson@uwe.ac.uk.; Rees B; University of the West of England, Bristol, United Kingdom.; Hull J; University of the West of England, Bristol, United Kingdom.; Heywood J; Bristol Haematology and Oncology Centre, University Hospital Bristol NHS Foundation Trust, Bristol, United Kingdom.; Preston A; Bristol Haematology and Oncology Centre, University Hospital Bristol NHS Foundation Trust, Bristol, United Kingdom.; Protheroe R; Bristol Haematology and Oncology Centre, University Hospital Bristol NHS Foundation Trust, Bristol, United Kingdom.; Foulstone E; Bristol Haematology and Oncology Centre, University Hospital Bristol NHS Foundation Trust, Bristol, United Kingdom.; Greenwood R; Bristol Haematology and Oncology Centre, University Hospital Bristol NHS Foundation Trust, Bristol, United Kingdom.; Salisbury V; University of the West of England, Bristol, United Kingdom.; Mehta P; Bristol Haematology and Oncology Centre, University Hospital Bristol NHS Foundation Trust, Bristol, United Kingdom.

Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2399 (Electronic) Linking ISSN: 0301472X NLM ISO Abbreviation: Exp Hematol Subsets: MEDLINE

Challapalli A; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.; Pearson S; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.; Mitra AV; University College London Hospitals NHS Foundation Trust, London, UK.; Coe M; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.; Thomson A; Royal Cornwall Hospitals NHS Trust, Truro, UK.; Elliott T; The Christie NHS Foundation Trust, Manchester, UK.; Kirkbride P; The Clatterbridge Cancer Centre NHS Foundation Trust, The Wirral, UK.; Pickering L; St Georges University Hospitals NHS Foundation Trust, London, UK.; Kirk H; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.; Foulstone E; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.; Evans H; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.; Bravo A; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.; Bahl AK; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK.

Publisher: Sage Publications Country of Publication: England NLM ID: 0346411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-2300 (Electronic) Linking ISSN: 03000605 NLM ISO Abbreviation: J Int Med Res Subsets: MEDLINE